{"id":"https://openalex.org/W4281623600","doi":"https://doi.org/10.1136/jnnp-2022-abn.59","title":"020 Long-term efficacy of ocrelizumab in relapsing multiple sclerosis: 6 study years","display_name":"020 Long-term efficacy of ocrelizumab in relapsing multiple sclerosis: 6 study years","publication_year":2022,"publication_date":"2022-05-27","ids":{"openalex":"https://openalex.org/W4281623600","doi":"https://doi.org/10.1136/jnnp-2022-abn.59"},"language":"en","primary_location":{"id":"doi:10.1136/jnnp-2022-abn.59","doi":"https://doi.org/10.1136/jnnp-2022-abn.59","is_oa":false,"landing_page_url":"https://doi.org/10.1136/jnnp-2022-abn.59","pdf_url":null,"source":{"id":"https://openalex.org/S134773490","display_name":"Journal of Neurology Neurosurgery & Psychiatry","issn_l":"0022-3050","issn":["0022-3050","1468-330X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurology, Neurosurgery &amp; Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015754502","display_name":"Gavin Giovannoni","orcid":"https://orcid.org/0000-0001-9995-1700","observed_orcids":["https://orcid.org/0000-0001-9995-1700"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gavin Giovannoni","raw_affiliation_strings":["The Blizard Institute, Queen Mary University of London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Blizard Institute, Queen Mary University of London, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054874316","display_name":"Ludwig Kappos","orcid":"https://orcid.org/0000-0003-4175-5509","observed_orcids":["https://orcid.org/0000-0003-4175-5509"]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]},{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Ludwig Kappos","raw_affiliation_strings":["University Hospital Basel, University of Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Basel, University of Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I1850255","https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011213325","display_name":"Jerome De Seze","orcid":"https://orcid.org/0000-0002-7197-7578","observed_orcids":["https://orcid.org/0000-0002-7197-7578"]},"institutions":[{"id":"https://openalex.org/I4210145324","display_name":"H\u00f4pitaux Universitaires de Strasbourg","ror":"https://ror.org/04bckew43","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210145324"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jerome de Seze","raw_affiliation_strings":["University Hospital of Strasbourg, Strasbourg, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital of Strasbourg, Strasbourg, France","institution_ids":["https://openalex.org/I4210145324"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104805489","display_name":"Stephen L. Hauser","orcid":"https://orcid.org/0000-0002-4932-4001","observed_orcids":["https://orcid.org/0000-0002-4932-4001"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen L Hauser","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042748817","display_name":"James R. Overell","orcid":"https://orcid.org/0000-0002-3998-9819","observed_orcids":["https://orcid.org/0000-0002-3998-9819"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"James Overell","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071219650","display_name":"Harold Koendgen","orcid":"https://orcid.org/0000-0002-8496-4952","observed_orcids":["https://orcid.org/0000-0002-8496-4952"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Harold Koendgen","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114020720","display_name":"Kalpesh Prajapati","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088281","display_name":"Stedelijk Museum Amsterdam","ror":"https://ror.org/006a5r035","country_code":"NL","type":"archive","lineage":["https://openalex.org/I4210088281"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Kalpesh Prajapati","raw_affiliation_strings":["GCE Solutions Inc., Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GCE Solutions Inc., Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210088281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104210008","display_name":"Marianna Manfrini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Marianna Manfrini","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100434827","display_name":"Qing Wang","orcid":"https://orcid.org/0000-0002-3882-6540","observed_orcids":["https://orcid.org/0000-0002-3882-6540"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Qing Wang","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113533097","display_name":"Jerry S. Wolinsky","orcid":"https://orcid.org/0000-0002-8197-2762","observed_orcids":["https://orcid.org/0000-0002-8197-2762"]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jerry S Wolinsky","raw_affiliation_strings":["The University of Texas Health Science Center at Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas Health Science Center at Houston","institution_ids":["https://openalex.org/I919571938"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.07442917,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"93","issue":"6","first_page":"A19.3","last_page":"A20"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ocrelizumab","display_name":"ocrelizumab","score":1.0},{"id":"https://openalex.org/keywords/relapsing-multiple-sclerosis","display_name":"relapsing multiple sclerosis","score":0.9959999918937683},{"id":"https://openalex.org/keywords/interferon-beta-1a","display_name":"interferon beta-1a","score":0.8640000224113464},{"id":"https://openalex.org/keywords/treatment-switching","display_name":"treatment switching","score":0.7689999938011169},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.6620000004768372},{"id":"https://openalex.org/keywords/annualized-relapse-rate","display_name":"annualized relapse rate","score":0.9259999990463257},{"id":"https://openalex.org/keywords/confirmed-disability-progression","display_name":"confirmed disability progression","score":0.984000027179718},{"id":"https://openalex.org/keywords/expanded-disability-status-scale","display_name":"Expanded Disability Status Scale","score":0.7960000038146973},{"id":"https://openalex.org/keywords/long-term-efficacy","display_name":"long-term efficacy","score":0.7620000243186951},{"id":"https://openalex.org/keywords/early-treatment-initiation","display_name":"early treatment initiation","score":0.5040000081062317}],"concepts":[{"id":"https://openalex.org/C2778843634","wikidata":"https://www.wikidata.org/wiki/Q2013780","display_name":"Ocrelizumab","level":4,"score":0.9952126741409302},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7520149946212769},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.4636690616607666},{"id":"https://openalex.org/C2908698914","wikidata":"https://www.wikidata.org/wiki/Q2450337","display_name":"Interferon beta-1a","level":4,"score":0.4575047492980957},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41512322425842285},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.15969660878181458},{"id":"https://openalex.org/C2994247566","wikidata":"https://www.wikidata.org/wiki/Q2450337","display_name":"Interferon beta","level":3,"score":0.08936417102813721},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.0},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jnnp-2022-abn.59","doi":"https://doi.org/10.1136/jnnp-2022-abn.59","is_oa":false,"landing_page_url":"https://doi.org/10.1136/jnnp-2022-abn.59","pdf_url":null,"source":{"id":"https://openalex.org/S134773490","display_name":"Journal of Neurology Neurosurgery & Psychiatry","issn_l":"0022-3050","issn":["0022-3050","1468-330X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurology, Neurosurgery &amp; Psychiatry","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389447588","https://openalex.org/W2989866631","https://openalex.org/W76749292","https://openalex.org/W2810214780","https://openalex.org/W4389465430","https://openalex.org/W6886006237","https://openalex.org/W2903866675","https://openalex.org/W3045030255","https://openalex.org/W3136287523","https://openalex.org/W7220398354"],"abstract_inverted_index":{"Background":[0],"Efficacy/safety":[1],"of":[2,24,33,59,67,147,166,169,175,185,197],"ocrelizumab":[3,29,44,186],"in":[4,10,92,98,117,123,156,182],"relapsing":[5],"multiple":[6],"sclerosis":[7],"were":[8,81],"demonstrated":[9],"the":[11,22,34,93,124,142],"OPERA":[12],"I/II":[13],"(":[14],"NCT01247324":[15],"/NCT01412333)":[16],"double-blind":[17],"period":[18],"(DBP).":[19],"We":[20],"assessed":[21],"efficacy":[23],"switching":[25],"to":[26,50,96],"or":[27,46],"maintaining":[28],"after":[30],"4":[31,134],"years":[32,165],"open-label":[35],"extension":[36],"(OLE).":[37],"Methods":[38],"At":[39],"OLE":[40,99,109,132],"commencement,":[41],"patients":[42,170],"continued":[43],"(OCR-OCR)":[45,187],"switched":[47],"from":[48,78,90],"interferon-\u03b2-1a":[49],"OCR":[51],"(IFN-OCR).":[52],"Adjusted":[53],"annualised":[54],"relapse":[55],"rate":[56],"(ARR),":[57],"time-to-onset":[58],"24-week":[60],"confirmed":[61],"disability":[62],"progression":[63],"(CDP24)":[64],"and":[65,130,144,173],"risk":[66,146,174],"requiring":[68,148,176],"a":[69,149,177],"walking":[70,150,178],"aid":[71,151,179],"(Expanded":[72],"Disability":[73],"Status":[74],"Scale":[75],"score":[76],"\u22656.0)":[77],"DBP":[79,143],"baseline":[80],"analysed.":[82],"Results":[83],"Among":[84],"IFN-OCR":[85,121,160],"switchers,":[86],"ARR":[87],"decreased":[88],"year-on-year":[89,116],"0.2":[91],"pre-switch":[94,125],"year":[95,126],"0.04":[97],"Year":[100,110,133],"4;":[101],"OCR-OCR":[102,118,157],"continuers":[103,119,158],"maintained":[104,195],"low":[105],"ARRs":[106],"(pre-switch,":[107],"0.13;":[108],"4,":[111],"0.05).":[112],"CDP24":[113,172],"was":[114,152],"lower":[115,154,181],"versus":[120,159,188],"switchers":[122],"(7.7%":[127],"vs":[128,136],"12.0%)":[129],"at":[131],"(19.2%":[135],"23.7%);":[137],"p<0.05":[138],"all":[139],"comparisons.":[140],"Over":[141],"OLE,":[145],"44%":[153],"(p=0.004)":[155],"switchers.":[161],"Conclusions":[162],"After":[163],"6":[164],"follow-up,":[167],"rates":[168],"with":[171,200],"remained":[180],"earlier":[183,198],"initiators":[184],"those":[189],"initially":[190],"receiving":[191],"IFN":[192],"(IFN-OCR),":[193],"demonstrating":[194],"benefits":[196],"treatment":[199],"ocrelizumab.":[201],"g.giovannoni@qmul.ac.uk":[202]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-06-13T00:00:00"}